Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hepatitis B Surface Antigen-Specific Antibody (Anti-HBs)
- Target
- Anti-HBs
- Molecular classification
- Antibody, Immunoglobulin
01
Overview
Hepatitis B surface antigen-specific antibody production refers to the immune process by which B cells generate antibodies (primarily anti-HBs) that specifically recognize and bind to the hepatitis B surface antigen (HBsAg), a key protein on the envelope of the hepatitis B virus (HBV). The presence of these antibodies is a marker of protective immunity, either following recovery from acute HBV infection or successful vaccination. Anti-HBs antibodies neutralize HBV, mediate ADCC/ADCP, and form immune complexes. Detection in serum indicates immunity, while absence with persistent HBsAg suggests chronic infection. Modern techniques allow for development of therapeutic monoclonal antibodies.
- Other names
- Anti-Hepatitis B surface antigen antibodyAntibody to HBsAgHBsAb
02
Mechanism of action
Binding to HBsAg, blocking viral entry, and facilitating viral clearance through various mechanisms.
03
Biological functions
Neutralization of Hepatitis B virusAntibody-dependent cellular cytotoxicity (ADCC)Antibody-dependent cellular phagocytosis (ADCP)OpsonizationImmune complex formation
04
Disease associations
Hepatitis B virus infectionImmune response to vaccination
05
Safety considerations
Potential for immune complex-mediated adverse events (rare)Variable response to vaccination in certain populations (e.g., immunocompromised)
06
Interacting drugs
Recombinant Hepatitis B vaccines
2 more in the full profile.
07
Biomarkers
Presence of anti-HBs in serum indicates immunityAbsence of anti-HBs with persistent HBsAg indicates chronic infection
Beyond the preview
Go deeper on Hepatitis B Surface Antigen-Specific Antibody (Anti-HBs).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hepatitis B Surface Antigen-Specific Antibody (Anti-HBs).